Literature DB >> 26666821

The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.

Zhanlong Shen1, Yichao Yan2, Chunxiang Ye2, Bo Wang2, Kewei Jiang2, Yingjiang Ye2, Harri Mustonen3, Pauli Puolakkainen4, Shan Wang5.   

Abstract

Vasohibin-1 is an intrinsic inhibitor of angiogenesis induced by VEGF-A. However, there little is known about the relationship between Vasohibin-1 expression, angiogenesis, and tumor-associated macrophages (TAMs). Vasohibin-1 expression, VEGF-A expression, microvessel density (MVD) marked with CD34, and density of cells marked with CD68 were measured in 111 paraffin-embedded tissues of gastric cancer by immunohistochemistry. The length of tube forming structures of endothelial cells and mobility rate of gastric cancer cells in Matrigel were tested by three-dimensional live cell imaging system. The effect of TAMs on the tumor growth, MVD, and Vasohibin-1 expression was measured by nude mice tumor genesis assay in vivo. We found that high Vasohibin-1 protein expression correlated significantly with worse TNM stage (P = 0.002), metastatic lymph node (P = 0.014), distant metastasis (P = 0.022), overall survival (P < 0.001), and progression-free survival (P < 0.001) compared to those with low Vasohibin-1 expression. Vasohibin-1 protein expression had statistical correlation with the MVD (r = 0.860, P < 0.001), density of CD68(+) cells (r = 0.882, P < 0.001), and VEGF-A expression (r = 0.719, P < 0.001) in the gastric cancer tissues. Decreasing Vasohibin-1 expression with siRNA increased the length of tube forming structures of endothelial cells in co-culture with endothelial cells (EA-hy923), macrophages, and gastric cancers (Hs746T). Tumor volume (P = 0.001), Vasohibin-1 (P < 0.001), and VEGF-A (P < 0.001) expression in mice inoculated with AGS and THP (10:1) was significantly higher than that with AGS alone (P = 0.001). Vasohibin-1 protein expression had statistical correlation with VEGF expression (r = 0.786, P < 0.001) and MVD (r = 0.496, P = 0.014) in gastric xenografted tumor. Therefore, Vasohibin-1 might be a potential marker of worse prognosis and therapeutic target in gastric cancer. Vasohibin-1 might play an important role in the process of angiogenesis regulated by TAMs.

Entities:  

Keywords:  Angiogenesis; Gastric cancer; Prognosis; TAMs; Vasohibin-1

Mesh:

Substances:

Year:  2015        PMID: 26666821     DOI: 10.1007/s13277-015-4595-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

Review 1.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

2.  The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.

Authors:  Keigo Murakami; Atsuko Kasajima; Naoki Kawagishi; Satoshi Sekiguchi; Fumiyoshi Fujishima; Mika Watanabe; Yasufumi Sato; Noriaki Ohuchi; Hironobu Sasano
Journal:  Hum Pathol       Date:  2013-11-06       Impact factor: 3.466

3.  Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs.

Authors:  Zhanlong Shen; Tuuli Kauttu; Hanna Seppänen; Sanna Vainionpää; Yingjiang Ye; Shan Wang; Harri Mustonen; Pauli Puolakkainen
Journal:  Med Oncol       Date:  2012-03-22       Impact factor: 3.064

4.  Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.

Authors:  Naoki Kanomata; Yasufumi Sato; Yoshiyuki Miyaji; Atsushi Nagai; Takuya Moriya
Journal:  J Clin Pathol       Date:  2013-03-29       Impact factor: 3.411

5.  Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.

Authors:  Takahito Kitajima; Yuji Toiyama; Koji Tanaka; Susumu Saigusa; Minako Kobayashi; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Anticancer Res       Date:  2014-10       Impact factor: 2.480

6.  Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression.

Authors:  Manesh Chittezhath; Manprit Kaur Dhillon; Jyue Yuan Lim; Damya Laoui; Irina N Shalova; Yi Ling Teo; Jinmiao Chen; Revathy Kamaraj; Lata Raman; Josephine Lum; Thomas Paulraj Thamboo; Edmund Chiong; Francesca Zolezzi; Henry Yang; Jo A Van Ginderachter; Michael Poidinger; Alvin S C Wong; Subhra K Biswas
Journal:  Immunity       Date:  2014-10-30       Impact factor: 31.745

7.  Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.

Authors:  Kentaro Tamaki; Hironobu Sasano; Yohei Maruo; Yayoi Takahashi; Minoru Miyashita; Takuya Moriya; Yasufumi Sato; Hisashi Hirakawa; Nobumitsu Tamaki; Mika Watanabe; Takanori Ishida; Noriaki Ohuchi
Journal:  Cancer Sci       Date:  2010-04       Impact factor: 6.716

8.  Induction and expression of anti-angiogenic vasohibins in the hematopoietic stem/progenitor cell population.

Authors:  Hisamichi Naito; Hiroyasu Kidoya; Yasufumi Sato; Nobuyuki Takakura
Journal:  J Biochem       Date:  2009-01-29       Impact factor: 3.387

9.  Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.

Authors:  Kousuke Yoshinaga; Kiyoshi Ito; Takuya Moriya; Satoru Nagase; Tadao Takano; Hitoshi Niikura; Nobuo Yaegashi; Yasufumi Sato
Journal:  Cancer Sci       Date:  2008-03-03       Impact factor: 6.716

10.  A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.

Authors:  Yichao Yan; Zhanlong Shen; Yingjiang Ye; Kewei Jiang; Hui Zhang; Chao Shen; Harri Mustonen; Pauli Puolakkainen; Shan Wang
Journal:  Med Oncol       Date:  2013-12-24       Impact factor: 3.064

View more
  1 in total

1.  Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma.

Authors:  Bo You; Xiaolei Cao; Xiaoyi Shao; Haosheng Ni; Si Shi; Ying Shan; Zhifeng Gu; Yiwen You
Journal:  Oncotarget       Date:  2016-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.